International Clinical Trial: A study to investigate the efficacy, safety, and pharmacokinetics of oral rilzabrutinib compared with placebo in participants 18 years of age and older with warm autoimmune hemolytic anemia

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2031250270) titled 'A study to investigate the efficacy, safety, and pharmacokinetics of oral rilzabrutinib compared with placebo in participants 18 years of age and older with warm autoimmune hemolytic anemia' on Aug. 1.

Study Type: Interventional

Study Design: randomized controlled trial, open(masking not used), placebo control, parallel assignment, treatment purpose

Primary Sponsor: Obara Kentaro

Condition: Autoimmune haemolytic anaemia

Intervention: Drug: rilzabrutinib (SAR444671) Pharmaceutical form: tablet, Route of administration: oral Drug: placebo Pharmaceutical form: tablet, Route of administration: oral

Stud...